EXHIBIT 10.27 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD, TRANSFERRED OR...Warrant Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
LEASE AGREEMENT (CONTINUED)Lease Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Washington
WARRANTWarrant Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
300,000.00 APRIL 17, 2006 SECTION 1. GENERAL. For value received, NORTHWEST BIOTHERAPEUTICS, INC., a Delaware corporation (the "MAKER" or the "COMPANY"), hereby promises to pay to the order of Toucan Partners, LLC or its assigns (collectively, the...Loan Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Exhibit 10.23 NORTHWEST BIOTHERAPEUTICS AMENDED AND RESTATED RECAPITALIZATION AGREEMENT This AMENDED AND RESTATED RECAPITALIZATION AGREEMENT (this "AGREEMENT") is made by and between NORTHWEST BIOTHERAPEUTICS, INC., and its affiliates, if any...Recapitalization Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
The Company shall have in all material respects performed, and be in compliance with, all obligations, agreements, covenants, closing conditions and other provisions contained in the Amended and Restated Recapitalization Agreement by and between the...Convertible Preferred Stock Term Sheet • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
CLINICAL STUDY AGREEMENTClinical Study Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, on behalf of its Los Angeles Campus (hereinafter “University”), and Northwest Biotherapeutics Inc., (hereinafter “Company”), agree that University will perform for a clinical study (hereinafter “the Study”) in accordance with the protocol entitled “Phase 1 Clinical Trial Evaluating Booster Vaccinations of DCVax®-Brain for Treatment of Glioblastoma” (attached as Exhibit A) on the following terms and conditions:
RECITALSInvestor Rights Agreement • April 18th, 2006 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
